Literature DB >> 30472224

Repeatability of Regional Lung Ventilation Quantification Using Fluorinated (19F) Gas Magnetic Resonance Imaging.

Marcel Gutberlet1, Till F Kaireit1, Andreas Voskrebenzev1, Agilo L Kern1, Arnd Obert1, Frank Wacker1, Jens M Hohlfeld2, Jens Vogel-Claussen3.   

Abstract

RATIONALE AND
OBJECTIVES: To assess the repeatability of global and regional lung ventilation quantification in both healthy subjects and patients with chronic obstructive pulmonary disease (COPD) using fluorinated (19F) gas washout magnetic resonance (MR) imaging in free breathing.
MATERIAL AND METHODS: In this prospective institutional review board-approved study, 12 healthy nonsmokers and eight COPD patients were examined with 19F dynamic gas washout MR imaging in free breathing and with lung function testing. Measurements were repeated within 2 weeks. Lung ventilation was quantified using 19F gas washout time. Repeatability was analyzed for the total lung and on a regional basis using the coefficient of variation (COV) and Bland-Altman plots.
RESULTS: In healthy subjects and COPD patients, a good repeatability was found for lung ventilation quantification using dynamic 19F gas washout MR imaging on a global (COV < 8%) and regional (COV < 15%) level. Gas washout time was significantly increased in the COPD group compared to the healthy subjects.
CONCLUSION: 19F gas washout MR imaging provides a good repeatability of lung ventilation quantification and appears to be sensitive to early changes of regional lung function alterations such as normal aging.
Copyright © 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (19)F; COPD; Fluorine; Gas washout; Lung; Magnetic resonance; Pulmonary

Mesh:

Year:  2018        PMID: 30472224     DOI: 10.1016/j.acra.2018.10.021

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  5 in total

1.  Reproducibility of 19 F-MR ventilation imaging in healthy volunteers.

Authors:  Benjamin J Pippard; Mary A Neal; Adam M Maunder; Kieren G Hollingsworth; Alberto Biancardi; Rod A Lawson; Holly Fisher; John N S Matthews; A John Simpson; Jim M Wild; Peter E Thelwall
Journal:  Magn Reson Med       Date:  2021-01-28       Impact factor: 4.668

Review 2.  State-of-the-art MR Imaging for Thoracic Diseases.

Authors:  Yumi Tanaka; Yoshiharu Ohno; Satomu Hanamatsu; Yuki Obama; Takahiro Ueda; Hirotaka Ikeda; Akiyoshi Iwase; Takashi Fukuba; Hidekazu Hattori; Kazuhiro Murayama; Takeshi Yoshikawa; Daisuke Takenaka; Hisanobu Koyama; Hiroshi Toyama
Journal:  Magn Reson Med Sci       Date:  2021-04-29       Impact factor: 2.760

Review 3.  Interleaved and simultaneous multi-nuclear magnetic resonance in vivo. Review of principles, applications and potential.

Authors:  Alfredo L Lopez Kolkovsky; Pierre G Carlier; Benjamin Marty; Martin Meyerspeer
Journal:  NMR Biomed       Date:  2022-04-27       Impact factor: 4.478

4.  Defect distribution index: A novel metric for functional lung MRI in cystic fibrosis.

Authors:  Anne Valk; Corin Willers; Kamal Shahim; Orso Pusterla; Grzegorz Bauman; Robin Sandkühler; Oliver Bieri; Florian Wyler; Philipp Latzin
Journal:  Magn Reson Med       Date:  2021-08-02       Impact factor: 3.737

5.  Comparison of single breath hyperpolarized 129 Xe MRI with dynamic 19 F MRI in cystic fibrosis lung disease.

Authors:  Andrew McCallister; Sang Hun Chung; Michael Antonacci; Margret Z Powell; Agathe S Ceppe; Scott H Donaldson; Yueh Z Lee; Rosa Tamara Branca; Jennifer L Goralski
Journal:  Magn Reson Med       Date:  2020-08-08       Impact factor: 4.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.